POMDOCTOR Advances AI-Enabled Chronic Disease Management Strategy
POMDOCTOR Limited highlighted its ongoing efforts to build an AI-powered chronic disease management ecosystem. The company is integrating artificial intelligence, remote patient monitoring, wearable technologies, and real-world healthcare data to evolve into a predictive, continuous, and personalized healthcare service provider. This strategy aligns with market trends, as the global AI chronic disease prevention market is projected to grow significantly from $30.2 billion in 2026 to $488.4 billion by 2035.
Key Highlights
- POMDOCTOR is advancing its AI-enabled chronic disease management strategy.
- The company integrates AI, remote patient monitoring, wearables, and real-world data.
- Global AI chronic disease prevention market is projected to reach $488.4 billion by 2035.
- This market is expected to grow at a CAGR of 36.2% from $30.2 billion in 2026.
- Global chronic disease management technology market to grow from $7.21 billion (2025) to $15.01 billion (2033).
- The company aims to transition from reactive treatment to predictive, personalized healthcare.
Price Impact
More from POM
POMDOCTOR Receives Nasdaq Delisting Warnings for MVLS and MVPHS Deficiencies
POMDOCTOR Highlights Differentiated 'Hardware + AI + Payment' Healthcare Model
Pomdoctor Highlights Healthcare Intelligence Flywheel as Growth Engine